Identification of the non-proteolytic mechanism of NLRP1 activation
Identification of the non-proteolytic mechanism of NLRP1 activation
批准号:
9234453
负责人:
Sarah E. Ewald
金额:
$10.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-03-01 至 2018-07-31
关键词:
AddressAllelesAmino AcidsAnthrax diseaseAreaAutoimmune DiseasesAutoimmune ProcessAutoimmunityAwardBacillus anthracisBacteriaBacterial InfectionsBindingBiological AssayBiologyBone MarrowCell DeathCellsChemicalsCleaved cellComplementComplexDataDetectionDevelopmentDiseaseEpitopesFlagellinGenesGenetic EngineeringGenetic ScreeningGoalsHumanImmuneImmune responseImmunofluorescence ImmunologicImmunologyImmunoprecipitationIndividualInfectionInfectious AgentInflammasomeInflammationInflammation MediatorsInflammatory ResponseInnate Immune SystemInterventionK22 AwardLeadLightMediatingModelingMolecularN-terminalParasitesPathway interactionsPeptide HydrolasesProcessProductionProteolysisRattusResourcesRestRodentRoleRouteSystemTimeToxoplasmaToxoplasma gondiiTrainingTranslatingVaccinesVariantVirusVirus DiseasesWorkanthrax lethal factorautoinflammatorybiochemical toolscell injurycell typedesigngenetic approachgenome sequencingimmunosuppressedin vivokillingsmacrophagemicrobialmutantnovelpathogenpublic health relevanceresponsereverse geneticssensorskillstherapeutic developmenttherapy developmenttooltumorvaccine developmentvaccine responsevaccinology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Inflammasomes are innate immune sensing pathways designed to identify and clear infectious agents through production of pro-inflammatory mediators and pyroptotic cell death. Selective targeting of inflammasomes and their sensors, the NLRPs, is emerging as an important means of modulating the immune response in vaccinology, tumor therapy and treatment of autoimmunity. However, only two molecular mechanisms of NLRP activation have been described to date: NLRP1 proteolysis by Bacillus anthracis lethal factor and flagellin binding by the NAIPs/NLRC4 inflammasome. I have recently determined that NLRP1 also drives a host-protective inflammasome response to the protozoan parasite Toxoplasma gondii. In contrast to the previously described mechanism of NLRP1 activation by anthrax, however, NLRP1 is not proteolytically processed in response to Toxoplasma infection, leading to the hypothesis that NLRP1 has evolved to detect parasite infection via a novel, undescribed mechanism. This K22 award will provide the experimental resources, time and training to identify the critical components of the NLRP1 sensing pathway.
Specifically, this award will allow me to develop 1) skills in the design and implementation of forward genetic screens, 2) tools and expertise in reverse genetic engineering of parasites, 3) biochemical tools to probe the essential components of NLRP1 for sensor activation. These studies address an understudied area in immunology: how eukaryotic pathogens are sensed by the innate immune system. Moreover, by exploiting the natural allelic variation in NLRP1 in parallel with a parasite genetics approach I will establish a unique set of tools to define the molecular underpinnings of NLRP1 activation that will be broadly important to our understanding of inflammasome biology. Specifically, the central goals of this project are to 1) identify the parasite components that trigger NLRP1 activation and 2) determine the critical residues in NLRP1 that mediate this response.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fimmu.2017.00301
发表时间:
2017
期刊:
Frontiers in immunology
影响因子:
7.3
作者:
[Tosello-Trampont A, Surette FA, Ewald SE, Hahn YS]
通讯作者:
Hahn YS
Innate Inflammatory Control of Cachexia
-
批准号:10210275
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule Attachment
-
批准号:10399599
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Innate Inflammatory Control of Cachexia
-
批准号:10028888
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Proteomic interrogation of the parasite vacuole using autoSTOMP
-
批准号:10307153
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule Attachment
-
批准号:10210393
-
项目类别:
-
资助金额:$23.82万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Innate Inflammatory Control of Cachexia
-
批准号:10404638
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Innate Inflammatory Control of Cachexia
-
批准号:10818772
-
项目类别:
-
资助金额:$3.76万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Improving Biomaterial Implant Tolerance with Damage-Associated Molecular Pathway (DAMP) Molecule Attachment
-
批准号:10057727
-
项目类别:
-
资助金额:$19.8万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
Innate Inflammatory Control of Cachexia
-
批准号:10624280
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2020
-
负责人:Sarah E. Ewald
-
依托单位:
海外基金